Real-world analysis of biomarker testing and use of targeted therapies in metastatic non-small cell lung cancer (mNSCLC) in the United States (US)

被引：0
|
作者：
Dennis, Michael J.
Abrahami, Devin
Vieira, Maria Cecilia
Benjumea, Darrin
Boyd, Marley
Shao, Anran
Duncan, Kirsten
Kelton, John
Patel, Sandip P.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2552
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world patterns of biomarker testing and targeted therapy in metastatic non-small cell lung cancer (mNSCLC) in the community oncology setting.
    Nadler, Eric S.
    Vasudevan, Anupama
    Davies, Kalatu
    Wang, Yunfei
    Gupta, Ravindra
    Ogale, Sarika
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Real-world biomarker testing trends in metastatic non-small cell lung cancer (NSCLC).
    Clinton, Natasha
    Patel, Manish R.
    Ayars, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18728 - E18728
  • [3] Real-world (RW) clinical outcomes of patients with metastatic non-small cell lung cancer (mNSCLC) in the United Kingdom
    Lester, J.
    Escriu, C.
    Khan, S.
    Hudson, E.
    Mansy, T.
    Conn, A.
    Chan, S.
    Powell, C.
    Brock, J.
    Conibear, J.
    Nelless, L.
    Nayar, V.
    Zhuo, X.
    Durand, A.
    Amin, A.
    Martin, P.
    Zhang, X.
    Pawar, V.
    ANNALS OF ONCOLOGY, 2020, 31 : S878 - S879
  • [4] REAL-WORLD BIOMARKER TESTING RATES AMONG PATIENTS WITH WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE UNITED STATES
    Vieira, M. C.
    Kelton, J. M.
    Lamarre, N.
    Abraham, A.
    Duncan, K.
    Krulewicz, S.
    VALUE IN HEALTH, 2022, 25 (07) : S437 - S437
  • [5] REAL-WORLD PATTERNS OF BIOMARKER TESTING IN METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Roncadori, A.
    Massa, I
    Balzi, W.
    Danesi, V
    Rengucci, C.
    Gentili, N.
    Crino, L.
    Delmonte, A.
    Altini, M.
    VALUE IN HEALTH, 2022, 25 (01) : S255 - S255
  • [6] Biomarker testing and targeted therapy use among patients with non-small cell lung cancer in the United States: An analysis using a physician notes real-world database.
    Videna, Vernon
    Iwanyckyj, Dave
    Otalora, Fernando
    Jardim, Melanie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Disparities in biomarker testing practices in patients with metastatic non-small cell lung cancer (NSCLC) in the United States (US)
    Dennis, Michael J.
    Abrahami, Devin
    Vieira, Maria Cecilia
    Benjumea, Darrin
    Boyd, Marley
    Shao, Anran
    Duncan, Kirsten
    Kelton, John
    Patel, Sandip P.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Economic Burden of Metastatic Non-Small Cell Lung Cancer (mNSCLC) in a Large United States (US) Claims Database
    Chou, E.
    Ganti, A. K.
    Katranji, K.
    Cotarla, I.
    Sharma, C.
    Miao, B.
    Garg, M.
    Seal, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S11 - S12
  • [9] Real-World Biomarker Testing and Treatment Patterns for Locally Advanced and Metastatic Non-Small Cell Lung Cancer in Canada
    Laforty, C.
    Tong, M.
    Sharma, A.
    Kim, Y.
    Devost, N.
    Qadeer, R.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S656 - S657
  • [10] Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States
    Enewold, Lindsey
    Thomas, Anish
    PLOS ONE, 2016, 11 (06):
12345